<DOC>
	<DOC>NCT01604733</DOC>
	<brief_summary>Study objective is to evaluate the level of control of hypercholesterolemia in Egypt in patients taking lipid lowering agents for at least 3 months ( with no drug change or dose amendment for a minimum of 6 weeks).</brief_summary>
	<brief_title>Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia</brief_title>
	<detailed_description>Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>18 years and above on current lipid lowering drug for at least 3 months with no dose change for a minimum of 6 weeks Subject must provide informed consent and comply with the survey procedures Less than 18 years less than 3 months on antidyslipidemic agent Subjects who are unwilling or unable to provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Multi-Center Survey</keyword>
	<keyword>patients currently on lipid-lowering pharmacological treatment</keyword>
	<keyword>level of Control of Hypercholesterolemia in Egypt</keyword>
</DOC>